Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

Ovarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and pathophysiological p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Frontiers in immunology Ročník 16; s. 1639853
Hlavní autori:	Ibrahim, Dalia, Grondin, Melanie, Galpin, Kristianne, Asif, Sara, Thompson, Emily, Nersesian, Sarah, Abou-Hamad, John, Echaibi, Maryam, Rodriguez, Galaxia M., Navals, Pauline, Macdonald, Elizabeth, Ryan, Brianna, Cook, David P., Keillor, Jeffrey W., Vanderhyden, Barbara C.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media S.A 24.07.2025
Predmet:	Animals Cell Line, Tumor Disease Models, Animal Female GTP-Binding Proteins Humans immune modulation Immunology metastasis Mice Neoplasm Metastasis ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - immunology Ovarian Neoplasms - pathology Protein Glutamine gamma Glutamyltransferase 2 - antagonists & inhibitors Protein Glutamine gamma Glutamyltransferase 2 - metabolism targeted therapy transglutaminase 2 Transglutaminases - antagonists & inhibitors Transglutaminases - genetics Transglutaminases - metabolism Tumor Microenvironment - immunology Xenograft Model Antitumor Assays targeted therapy transglutaminase 2 immune modulation metastasis ovarian cancer
ISSN:	1664-3224, 1664-3224
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!